✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Venmax Drugs And Pharmaceuticals Ltd.

VENMAX

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹20 Cr.
P/E
0.00

Venmax Drugs And Pharmaceuticals Ltd.

  • Venmax Drugs&Pharma
  • Hamps Bio
  • Ishita Drugs & Inds.

FAQs on Venmax Drugs And Pharmaceuticals Ltd. Shareprice

Venmax Drugs&Pharma has given better returns compared to its competitors.
Venmax Drugs&Pharma has grown at ~162.03% over the last 2yrs while peers have grown at a median rate of 1.0%

There is insufficient historical data to gauge this.
Latest PE of Venmax Drugs&Pharma is 0

View FAQ's On Business

Growth Table

  • Venmax Drugs And Pharmaceuticals Ltd.
  • Hamps Bio
  • Ishita Drugs & Inds.

Balance Sheet

  • Venmax Drugs And Pharmaceuticals Ltd.
  • Hamps Bio
  • Ishita Drugs & Inds.

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Venmax Drugs And Pharmaceuticals Ltd.
  • Hamps Bio
  • Ishita Drugs & Inds.

Cash Flow

  • Venmax Drugs And Pharmaceuticals Ltd.
  • Hamps Bio
  • Ishita Drugs & Inds.

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Venmax Drugs And Pharmaceuticals Ltd.
  • Hamps Bio
  • Ishita Drugs & Inds.

Quarterly Results

  • Venmax Drugs And Pharmaceuticals Ltd.
  • Hamps Bio
  • Ishita Drugs & Inds.

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Venmax Drugs And Pharmaceuticals Ltd. Financials

Balance sheet of Venmax Drugs&Pharma is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Venmax Drugs&Pharma is increasing.
Latest net debt of Venmax Drugs&Pharma is -₹2.47 Crs as of Jun-25.
This is greater than Mar-25 when it was -₹4.92 Crs.

No, profit is decreasing.
The profit of Venmax Drugs&Pharma is -₹0.01 Crs for Mar 2025, ₹0.06 Crs for Mar 2024 and ₹0.23 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Venmax Drugs&Pharma latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech